510(k) Report

510(k) · Cleared

Cleared

deepLive (OSP12 + DMS)

K252851510(k) SpecialCleared Oct 7, 202529-day reviewClass II21 CFR 892.1560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Damae Medical · NQQ System, Imaging, Optical Coherence Tomography (Oct)

Cleared on Oct 7, 2025 as substantially equivalent to K240610 (Damae Medical, 2024) after a 29-day review. Its family tree reaches back 2 generations to 2016.

Decided
Oct 7, 2025
Review
29 days
Class
Class II
Product code
NQQ
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K153283 (2016). No later device cites it as a predicate yet.

  1. Root · 2 generations backK153283 VivoSight Dx Topical OCT SystemMichelson Diagnostics, Ltd. · 2016
  2. 1 generation backK240610 deepLiveDamae Medical · 2024
  3. This deviceK252851 deepLive (OSP12 + DMS)Damae Medical · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K153283VivoSight Dx Topical OCT SystemMichelson Diagnostics, Ltd.2016—
−1K240610deepLiveDamae Medical2024—
0 (this device)K252851deepLive (OSP12 + DMS)Damae Medical2025—
FIG. 1 — Lineage of K252851, 2016–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NQQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NQQ device

  1. #1 K251730 LIA Console (542-7)score 16.2 · 20 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K240610deepLive
Summary page 5
…ystem Product Code NQQ Regulatory Class II Predicate Device Proprietary Name deepLive Premarket Notification K240610 Classification Name Radiology Regulation Number 21 CFR 892.1560 Regulation Name Ultraso…
Damae Medical2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 2 companies; a new generation was cleared every 7.9 years on median.
  • None of the 2 ancestors has a recall.

How does its category compare?

All NQQ devices

NQQ System, Imaging, Optical Coherence Tomography (Oct): FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · NQQ

8in 2025

2010: 32011: 22012: 12013: 22014: 22015: 52016: 52017: 12018: 22019: 32020: 22021: 22023: 32024: 22025: 82026 (partial year): 1
2007high 8 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NQQ

146in 2025

2010: 82 days median2015: 91 days median2016: 91 days median2019: 84 days median2023: 86 days median2025: 146 days median
2007high 146 (2025) · low 82 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NQQ

1in 2011

2010: 12011: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NQQ

2in 2025

2011: 22012: 52013: 32014: 12015: 32016: 22017: 32018: 42019: 62020: 42021: 32022: 42023: 62024: 62025: 2
2007high 6 (2019) · low 0 (2007)2025

MAUDE reports naming product code NQQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
201038210
20112—12
20121—05
20132—03
20142—01
201559103
201659102
20171—03
20182—04
201938406
20202—04
20212—03
20220—04
202338606
20242—06
2025814602
20261—0—

What is it indicated for?

deepLive is intended to be used as a non-invasive imaging tool in the evaluation of external human tissue microstructure by providing three-dimensional, cross-sectional and en-face real-time depth visualization for assessment by physicians to support in forming a clinical judgment.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252851: deepLive (OSP12 + DMS).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252851

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026